Picture of CHA Vaccine Research Institute logo

261780 CHA Vaccine Research Institute Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for CHA Vaccine Research Institute, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-2,980-6,240-18,420-6,715-1,749
Depreciation
Amortisation
Non-Cash Items1982,44713,016996-4,198
Unusual Items
Other Non-Cash Items
Changes in Working Capital-345-299419114121
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-3,093-3,954-4,740-5,189-5,293
Capital Expenditures-124-53.5-683-447-291
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-6,161-6,818-46,7804,18422,221
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-6,285-6,872-47,4633,73621,930
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities12,03519,99144,320-116-13,117
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2,6579,165-7,883-1,5683,520